We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nova Alternative RNA Splicing Targets Neuronal Proteins

By Biotechdaily staff writers
Posted on 26 Nov 2003
A new study describes a method to purify protein-RNA complexes from mouse brain that allows researchers to identify an array of RNA molecules regulated by Nova, an RNA-binding protein that regulates alternative RNA splicing.

Nova proteins are neuron-specific antigens targeted in paraneoplastic opsoclonus myoclonus ataxia (POMA), an autoimmune neurologic disease characterized by abnormal motor inhibition. More...
Nova proteins regulate neuronal pre-messenger RNA splicing by directly binding to RNA.

RNA splicing is an essential, precisely regulated post-transcriptional process that occurs prior to mRNA translation. A gene is first transcribed into a pre-messenger RNA (pre-mRNA), which is a copy of the genomic DNA containing intronic regions destined to be removed during pre-mRNA processing (RNA splicing), as well as exonic sequences that are retained within the mature mRNA. During RNA splicing, exons can either be retained in the mature message or targeted for removal in different combinations to create a diverse array of mRNAs from a single pre-mRNA, a process referred to as alternative RNA splicing.

Alternative splice events that affect the protein coding region of the mRNA will give rise to proteins that differ in their sequence and therefore in their activities. Alternative splicing within the noncoding regions of the RNA can result in changes in regulatory elements such as translation enhancers or RNA stability domains, which may have a dramatic effect on the level of protein expression.

Investigators at Rockefeller University (New York, NY, USA; www.rockefeller.edu) employed a technique called cross-linking and immunoprecipitation (CLIP) to chemically bond the NOVA protein to its RNA targets. In a novel adaptation of this method, they applied it to intact mouse brains in order to trap the protein-RNA complexes as they are in situ. In the November 14, 2003, issue of Science, they reported that 34 transcripts were identified multiple times by Nova CLIP. Three-quarters of these encoded proteins functioned at the neuronal synapse, and one-third were involved in neuronal inhibition.

"Looking at these targets as a group, they have a tremendous biological coherence to them,” observed senior author Dr. Robert B. Darnell, a Howard Hughes Medical Institute investigator at Rockefeller University. "Almost 70% of them are RNAs that have something to do with the neuronal synapse. One-third of the Nova synaptic RNA targets encode proteins involved in inhibiting neuronal function. Regulating neuronal inhibition plays a key role in the balance-controlling nervous system function normally as well as in neurological disorders such as epilepsy.”



Related Links:
Rockefeller University

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Automated Urinalysis Solution
UN-9000
New
Thyroid Test
Anti-Thyroid EIA Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Photo courtesy of Adobe Stock

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.